• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE Back to Search Results
Catalog Number UNKNOWN
Device Problem Migration (4003)
Patient Problem Insufficient Information (4580)
Event Date 04/12/2016
Event Type  Injury  
Manufacturer Narrative
Pma/510(k) # k163468.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Amelung, 2016 ¿ deviating colostomy construction versus stent placement as bridge to surgery for malignant left-sided colonic obstruction.All patients underwent the initial decompression procedure within 48 h after presentation with obstructive symptoms.The gastrointestinal surgeon on call performed the colostomy constructions, while sems placement was performed by one of three expert endoscopists with a minimum of 4-year experience ([20 procedures) with colonic stent placement.Colostomies were constructed on the right transverse colon.An incision was made in the right upper abdominal quadrant; the transverse colon was elevated to the skin, temporarily anchored with a plastic rod and fixed with resolvable stitches.Four different stent types were used, based on availability, i.E., wallstent _ (boston scientific, natrick, ma, usa), wallflex_ (boston scientific), ultraflex_ (boston scientific) and evolution_ (cook medical, limerick, ireland).After colostomy construction or stent placement, patients received enteral feeding as soon as possible.Elective resection was performed after approximately 2¿4 weeks.Six patients with technically successful stent placement did not have any relief of symptoms, due to: stent migration (n = 1).Patient outcome: require intervention/additional procedures s=4.Patient/event info - notes: as per fda guidance: average patient age and weight, as well as the gender of the majority of patients involved/individual patient info if available.
 
Manufacturer Narrative
Pma/510(k) # k163468.Device evaluation the device evaluation of evolution® colonic controlled-release stent ¿ uncovered of unknown lot number could not be completed as the device or photographic evidence of the device was not returned for evaluation.This file was created from the attached journal article amelung 2016.Additional files listed were opened as a results of this paper: 417435- amelung 2016 - perforation 417437 - amelung 2016 ¿ stent obstruction caused by fecal debris manufacturing records prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.Manufacturing records review could not be completed as the lot number is unknown.Review historical data historical data was not reviewed as the lot number is unknown.Instructions for use and/label the instructions for use, ifu0052 which accompanies this device, states ¿additional complications include, but are not limited to: intestinal perforation, pain, inadequate stent expansion, stent misplacement and/or migration, tumour ingrowth or overgrowth , stent occlusion , ulcerations, pressure necrosis , erosion of the luminal mucosa , septicaemia, foreign body sensation, bowel impaction , diarrhoea , constipation, peritonitis, symptoms of tenesmus or urgency/incontinence , death( other than due to normal disease progression ¿¿ there is no evidence to suggest that the customer did not follow the instructions for use.Image review an image was not returned for evaluation.Root cause analysis a definitive root cause could not be determined from the available information.A possible root cause could be attributed to patient condition, the instructions for use list stent migration as an additional complication.Is it known from the available information the stent was used to treat malignant colonic obstruction.Confirmation of complaint.Complaint is confirmed based on customer and/or rep testimony.Corrective action/ correction complaints of this nature will continue to be monitored for similar events.Summary of investigation according to the literature stent migration was reported in 1 patient.Confirmed quantity of 1 device, confirmed used.The patient required intervention/additional procedures due to this occurrence.Investigation findings conclude a definitive root cause was established.A possible root cause could be attributed to patient condition.Complaints of this nature will continue to be monitored for similar events.
 
Event Description
Supplemental report is being submitted due to the completion of the investigation on 20-may-2024.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED
Type of Device
MQR STENT, COLONIC METALLIC EXPANDABLE
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key18443466
MDR Text Key331881956
Report Number3001845648-2024-00003
Device Sequence Number1
Product Code MQR
Combination Product (y/n)N
Reporter Country CodeNL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Other
Type of Report Initial
Report Date 12/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/12/2016
Event Location Hospital
Initial Date Manufacturer Received 12/08/2023
Initial Date FDA Received01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexFemale
-
-